Isolated physiologically active human thrombomodulin polypeptide
CA 2042399 A1 · Owner: Gomi, Komakazu · Inventors: Yamamoto, Shuji; Ogawa, Kohei; Gomi, Komakazu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
71, Abstract of the Disclosure, Disclosed is an isolated polypeptide (type II polypeptide) comprising a physiologically active human thrombomodulin polypeptide which has the activity of promoting the thrombin-catalyzed activation of protein C and which has a sugar chain comprising chondroitin and/or chondroitin sulfate attached to the peptide chain of the polypeptide. The type II polypeptide of the present invention can be obtained in an isolated form from a conventional culture containing an expression product of the human thrombomodulin polypeptide gene which culture has been obtained by for example, recombinant DNA techniques. The type II polypeptide of the present invention has …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 25, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.